Valérie Laurent

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

Valérie Vilgrain, Héléna Pereira, Eric Assenat et al. · The Lancet Oncology · 2017 · 826 citations

Medicine, Oncology, Radiation Oncology +16

Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma

Abderrahim Oussalah, Susann Rischer, Mouni Bensenane et al. · EBioMedicine · 2018 · 169 citations · Full text

Medicine, Molecular Biology, Oncology +14

Curative Irradiation Treatment of Hepatocellular Carcinoma: A Multicenter Phase 2 Trial

Jérôme Durand-Labrunie, A.-S. Baumann, Ahmet Ayav et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 103 citations

Medicine, Oncology, Radiation Oncology +15

Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma

G. Oldrini, Andres Huertas, S. Renard-Oldrini et al. · PLoS ONE · 2017 · 36 citations · Full text

Medicine, Oncology, Radiology +17

CT imaging findings in patients with advanced hepatocellular carcinoma treated with sorafenib: Alternative response criteria (Choi, European Association for the Study of the Liver, and modified Response Evaluation Criteria in Solid Tumor (mRECIST)) versus RECIST 1.1

M. Gavanier, Ahmet Ayav, C. Sellal et al. · European Journal of Radiology · 2015 · 31 citations

Medicine, Oncology, Radiology +17